SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010255
Filing Date
2017-05-10
Accepted
2017-05-10 16:18:15
Documents
61
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 CLSD-10-Q-20170331 clsd-10q_20170331.htm 10-Q 1088971
2 EX-31.1 clsd-ex311_6.htm EX-31.1 15278
3 EX-31.2 clsd-ex312_8.htm EX-31.2 15273
4 EX-32.1 clsd-ex321_7.htm EX-32.1 9007
  Complete submission text file 0001564590-17-010255.txt   4562762

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clsd-20170331.xml EX-101.INS 1002338
6 XBRL TAXONOMY EXTENSION SCHEMA clsd-20170331.xsd EX-101.SCH 40826
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20170331_cal.xml EX-101.CAL 46290
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20170331_def.xml EX-101.DEF 96779
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20170331_lab.xml EX-101.LAB 290440
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20170331_pre.xml EX-101.PRE 212529
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 17830528
SIC: 2834 Pharmaceutical Preparations